This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| IGH | |
|---|---|
| Name | Immunoglobulin heavy locus |
| Chromosomal location | Chromosome 14q32.33 (human) |
| Gene type | Locus encoding immunoglobulin heavy chain segments |
| Organisms | Vertebrates (mammals, birds, fish) |
IGH
The immunoglobulin heavy locus is a genomic region encoding the variable (V), diversity (D), joining (J) and constant (C) segments required for antibody heavy chains in jawed vertebrates. It underpins somatic recombination processes that generate antigen receptor diversity and is central to adaptive responses mediated by B lymphocytes in vertebrate immunity. The locus has been extensively characterized in humans, mice, chickens and zebrafish using cytogenetics, high-throughput sequencing and molecular cloning.
The heavy chain locus contains arrays of V segments, D segments, J segments and multiple C genes organized to permit somatic recombination and class switching. In humans the locus resides at 14q32.33 and is neighbored by loci studied in clinical cytogenetics and oncogenomics. Research into the locus has intersected with studies of V(D)J recombination, AID (activation-induced cytidine deaminase), RAG1 and RAG2 functions, and with investigations of lymphoid malignancies such as multiple myeloma and diffuse large B-cell lymphoma.
The locus architecture includes hundreds of V segments upstream of a cluster containing D and J segments and multiple C region genes (mu, delta, gamma, epsilon, alpha) arranged in tandem. Comparative genomics across Homo sapiens, Mus musculus, Gallus gallus, Danio rerio and Canis lupus familiaris reveals differences in segment number, pseudogene content and repetitive element insertion. Structural features such as switch (S) regions, enhancers like Eµ and 3' regulatory regions, and CpG islands have been mapped using methods developed in genome assembly projects and consortiums like the Human Genome Project.
Expression of heavy chain transcripts is B cell developmental stage–dependent, with membrane-bound forms expressed during early stages and secreted isotypes produced after activation and differentiation into plasma cells. The locus enables antibody isotype diversification through class switch recombination mediated by AID and nonhomologous end joining factors characterized in studies of DNA repair pathways. Alternative splicing, polyadenylation site choice and promoter usage modulate expression of IgM, IgD, IgG, IgE and IgA constant regions, processes investigated in the context of B cell receptor signaling, germinal center reactions and vaccine responses.
Rearrangements and aberrant mutations at the locus are implicated in lymphoid neoplasms including Burkitt lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma and plasma cell disorders. Translocations that place oncogenes adjacent to heavy chain enhancers (for example involving MYC, BCL2, CCND1) drive dysregulated expression and tumorigenesis. Somatic hypermutation targeting the locus is studied in autoimmune disease contexts such as systemic lupus erythematosus and in the development of broadly neutralizing antibodies against pathogens like HIV-1 and influenza A virus.
Comparative analyses show conserved mechanistic themes across vertebrates, with lineage-specific expansions and contractions of V segment repertoires. Studies involving fossil-calibrated timetrees and molecular phylogenetics have compared Ig heavy loci among primates, rodentia, aves, teleostei and elasmobranchii to infer origins of V(D)J recombination. Conservation of RAG-mediated recombination signals and AID-related deamination underscores shared evolutionary pressures shaping adaptive immunity in jawed vertebrates.
Characterization employs targeted long-read sequencing, single-cell RNA-seq of B cell repertoires, chromatin conformation assays such as Hi-C, locus-specific chromatin immunoprecipitation (ChIP) for transcription factors like PAX5 and E2A, and CRISPR–Cas genetic perturbation in model organisms including Mus musculus and Danio rerio. Clinical diagnostics use fluorescence in situ hybridization (FISH) for translocations and PCR-based clonality assays standardized in pathology laboratories affiliated with institutions such as major cancer centers and reference labs.
Recurrent somatic events include V(D)J recombination junctional diversity producing complementarity-determining region variation, class switch recombination junctions, and oncogenic translocations such as t(8;14)(q24;q32) involving MYC and heavy chain enhancers in Burkitt lymphoma. Germline allelic polymorphisms in V segment sequences contribute to population-level differences observed in large consortium datasets and immunogenetic resources used by investigators studying vaccine responsiveness, infectious disease susceptibility, and antibody therapeutic development.
Category:Immunology Category:Genetics